These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6812357)

  • 21. Acquired factor VIII inhibitor in a patient with adenocarcinoma of the lung.
    Kondo H; Shigekiyo T; Kojima A; Saito S; Saijo N
    Jpn J Clin Oncol; 1992 Feb; 22(1):49-53. PubMed ID: 1573789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antifactor VIII antibody in Rosai-Dorfman disease].
    Lorenzini JL; Allain JP; Chalopin JM; Rifle G; Devilliers E; Carli PM; Cortet P; Bonhomme J
    Nouv Rev Fr Hematol (1978); 1983; 25(1):23-6. PubMed ID: 6403924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus and spontaneously arising anticoagulants.
    Jacobs P; Bracher M; Meyers OL
    S Afr Med J; 1975 Oct; 49(45):1881-2. PubMed ID: 1188558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
    Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
    Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical cases of acquired coagulation inhibitors].
    Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
    Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A 56-year-old patient with bronchial asthma and massive psoas muscle hematoma].
    Holler E; Hiller E; Hopfinger C; Meissner H
    Internist (Berl); 1986 Jun; 27(6):400-2. PubMed ID: 3091526
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritis.
    Pignone A; Matucci-Cerinic M; Morfini M; Lombardi A; Rossi Ferrini PL; Cagnoni M
    J Intern Med; 1992 Jun; 231(6):617-9. PubMed ID: 1619384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired factor VIII deficiency treated with cyclosporine].
    Leinøe EB; Jørgensen M; Nielsen JD
    Ugeskr Laeger; 1999 Aug; 161(34):4762-3. PubMed ID: 10500467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recurrent bleeding tendency due to factor VIII inhibitor during therapy for bullous pemphigoid].
    Kuboki T; Kudo T; Iwata N; Morimoto I
    Rinsho Ketsueki; 1999 Oct; 40(10):1087-92. PubMed ID: 10565226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsorption.
    Négrier C; Dechavanne M; Alfonsi F; Tremisi PJ
    Acta Haematol; 1991; 85(2):107-10. PubMed ID: 1902613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An acquired factor VIII inhibitor responsive to high-dose gamma globulin.
    Green D; Kwaan HC
    Thromb Haemost; 1987 Dec; 58(4):1005-7. PubMed ID: 2451304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disappearance of factor VIII antibodies upon frequent administration of factor VIII.
    Mauser-Bunschoten EP; Roosendaal G; Bruin M; van Dijken PJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):533-7. PubMed ID: 1714856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.
    Doma SA; Hillarp A; Pajič T; Andoljšek D; Černelč P; Preldžnik Zupan I
    Biochem Med (Zagreb); 2016; 26(2):279-84. PubMed ID: 27346976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired hemophilia: a case report.
    Flisiński M; Windyga J; Stefańska E; Huszcza S; Donderski R; Manitius J
    Pol Arch Med Wewn; 2008 Apr; 118(4):228-33. PubMed ID: 18575423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
    Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
    Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneously acquired factor VIII inhibitor in a non-haemophiliac child.
    Labbe A; Dubray C; Bezou MJ; Travade P; Coulet M
    Acta Paediatr Scand; 1983 Jul; 72(4):621-3. PubMed ID: 6414240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
    Muhm M; Grois N; Kier P; Stümpflen A; Kyrle P; Pabinger I; Bettelheim P; Hinterberger W; Lechner K
    Haemostasis; 1990; 20(1):15-20. PubMed ID: 2108912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.